Abstract:Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes (CTL) are an important parameter of host defenses that limit viral replication after infection. Induction of effective CTL against conserved viral proteins such as Gag may be essential to the development of a safe and effective HIV type 1 (HIV-1) vaccine. DNA vaccination represents a novel strategy for inducing potent CD8(+) CTL responses in vivo. However, expression of HIV-1 structural proteins by DNA vectors has been hampered by a stringent requirement for coexpression with other viral components, such as Rev and RRE. Furthermore, even with Rev and RRE present, the level of expression of HIV-1 Gag, pol, or Env is very low in murine cells. These problems have limited our ability to address the key issue of how to generate effective CTL responses to Gag in a mouse model. To overcome this problem, we compared several novel DNA expression vectors for HIV-1 Gag protein expression in primate and mouse cells and for generating immune responses in mice after DNA vaccination. A DNA vector containing wild type HIV-1 gag coding sequences did not induce detectable Gag expression in any of the cells tested. Attempts to increase nuclear export of Gag expression RNA by adding the constitutive transport element yielded only a moderate increase in Gag expression in monkey-derived COS cells and an even lower increase in Gag expression in HeLa cells or several mouse cell lines. In contrast, silent-site mutations in the HIV-1 gag coding sequences significantly increased Gag expression levels in all cells tested. Furthermore, this construct induced both Gag-specific antibody and CTL responses in mice after DNA vaccination. Using this construct, we achieved stable expression of HIV-1 Gag in the mouse cell line p815, which can now be used as a target cell for measuring HIV-1 Gag-specific CTL responses in immunized mice. The DNA vectors described in this study should make it possible to systematically evaluate the approaches for maximizing the induction of CTL responses against HIV-1 Gag in mouse and other animal systems.

Construction and Immunogenicity of Recombinant Modified Vaccinia Ankara Expressing HIV-1 Gag-Pol Antigen

Construction and Immunogenicity of HIV-1 DNA Vaccine

Construction of Replication-Deficient Recombinant Adenovirus Expressing Gag-Pola and Gp140tm Genes of Human Immunodeficiency Virus in Mice

Construction of a Recombinant HIV-1 Gp140 Protein Vaccine and Evaluation of Its Immunogenicity

[Construction of the Recombinant Lactococcus Lactis Expressing HIV-1 Gag Protein and Its Colonization in Mice].

Construction and Immunology of HIV-2 Gp105 and / or Gag DNA Vaccine

[Construction and Biological Characteristic for the Recombinant Modified Vaccinia Virus Ankara Co-Expressing Modified GP5 and M Protein of Porcine Reproductive and Respiratory Syndrome Virus].

Construction of Recombinant Fowlpox Virus(Rfpv) Expressing Hiv-1 Gag-Pol Protein

Construction of Expression Vector of Recombinant Vaccinia Virus TianTan Strain with C8L-K3L Region Deletion and Study on Biological Properties of the Recombinant Virus

Expression of HIV-1 Gag Protein in Recombinant Fowlpox Virus

Construction and Immunogenicity Analysis of a Vaccine Against HIV-1 AE Recombinant

A Mouse Model Based on Replication-Competent Tiantan Vaccinia Expressing Luciferase/Hiv-1 Gag Fusion Protein for the Evaluation of Protective Efficacy of Hiv Vaccine

Evaluation Of Novel Human Immunodeficiency Virus Type 1 Gag Dna Vaccines For Protein Expression In Mammalian Cells And Induction Of Immune Responses

[Study on the Immunogenicity of HIV-1 Gag Vaccine].

Construction and Vaccination of Recombinant HIV-1 DNA Vaccine for Therapeutic Use

Construction and Identification of Recombinant Modified Vaccine Virus Ankara for Expression of Late Protein L1 Gene of Human Papillomavirus Type 16

Enhancement of Primary and Secondary Cellular Immune Responses Against Human Immunodeficiency Virus Type 1 Gag by Using DNA Expression Vectors That Target Gag Antigen to the Secretory Pathway

Construction and Immunological Study of Recombinant Plasmid with HIV-1 Gag and IFN - Alpha2b

Construction and characterization of a recombinant fowlpox virus containing HIV-1 multi-epitope-p24 chimeric gene in mice

[Construction and Identification of DNA Vaccine Containing Chimeric Gene Gag-Gp120 of HIV-1].

[A Novel Double Expression Shuttle Vector to Get Marker-Free Recombinant Modified Vaccinia Virus Ankara].